Webinar

Effectively Screen Biotherapeutic Targets Using Carterra’s Powerful Software Suite

View

Peer-Reviewed Publication

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

View

Application Note

NiHC200M Biosensor Kinetic Assays on the Carterra® LSA®

View

Application Note

Rapid Kinetic and Antagonistic Profile Screening of Hybridoma Supernatants, a COVID-19 Case Study

View

Application Note

High Sensitivity Assay Development on the LSA®

View

Peer-Reviewed Publication

Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential

View

Webinar

Picking the Best Antibody Therapeutic Candidates to Develop the Most Effective COVID-19 Therapeutic Cocktail

View

Peer-Reviewed Publication

Presence and Strength of Binding of IgM, IgG and IgA Antibodies Against SARS-CoV-2 During COVID-19 Infection

View

Webinar

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein

View

Webinar

Accelerating Drug Discovery at a Pandemic Pace

View

Application Note

Monitoring Immune Response to SARS-CoV-2

View

Peer-Reviewed Publication

High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during COVID-19 infection

View

Webinar

Develop High Quality Therapeutic Antibodies Straight From Selections in Record Time

View

Webinar

Interview on the Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies

View